Filing Details

Accession Number:
0001209191-18-021609
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-26 15:39:48
Reporting Period:
2018-03-21
Accepted Time:
2018-03-26 15:39:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626878 Xbiotech Inc. XBIT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1638986 Queena Han 8201 East Riverside Drive
Building 4, Suite 100
Austin TX 78744
Vp Finance & Hr No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-21 9,599 $2.50 9,599 No 4 M Direct
Common Stock Disposition 2018-03-21 9,599 $4.48 0 No 4 S Direct
Common Stock Acquisiton 2018-03-22 62,200 $2.50 62,200 No 4 M Direct
Common Stock Disposition 2018-03-22 62,200 $4.76 0 No 4 S Direct
Common Stock Acquisiton 2018-03-23 8,201 $2.50 8,201 No 4 M Direct
Common Stock Disposition 2018-03-23 8,201 $4.75 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stocks Stock options Disposition 2018-03-21 9,599 $0.00 9,599 $2.50
Common Stock Stock options Disposition 2018-03-22 62,200 $0.00 62,200 $2.50
Common Stock Stock options Disposition 2018-03-23 8,201 $0.00 8,201 $2.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-04-22 2018-04-23 No 4 M Direct
0 2009-04-22 2018-04-23 No 4 M Direct
0 2009-04-22 2018-04-23 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.85, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.75 to $4.77, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.